Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Nov;3(11):753-760.
doi: 10.1016/j.trecan.2017.09.001. Epub 2017 Oct 24.

Breast Cancer: Multiple Subtypes within a Tumor?

Affiliations
Review

Breast Cancer: Multiple Subtypes within a Tumor?

Syn Kok Yeo et al. Trends Cancer. 2017 Nov.

Abstract

Breast cancer is a heterogeneous disease, and stratification of tumors is paramount to achieve better clinical outcomes. While it is common to stratify and treat breast tumors as a single entity, insights from studies on intratumoral heterogeneity and cancer stem cells raise the possibility that multiple breast cancer subtypes may coexist within a tumor. A role for plasticity in driving dynamic conversions between breast cancer subtypes is proposed, and the clinical implications include a need for combinatorial therapeutic strategies that account for the discrete disease entities and their plasticity. Accordingly, the advent of single-cell technologies will be crucial in enabling the diagnosis and stratification of distinct disease subtypes down to the cellular level.

Keywords: breast cancer; cancer stem cells; intratumoral heterogeneity; plasticity.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Association between differentiation states of the mammary gland hierarchy and intrinsic breast cancer subtypes
Depiction of differentiation states within the normal mammary gland hierarchy during embryonic development as well as in the postnatal mammary gland. Corresponding intrinsic breast cancer subtypes which are most closely associated with each state are illustrated (on the right).
Figure 2, Key Figure
Figure 2, Key Figure. Multiple breast cancer subtypes within a tumor and its therapeutic implications
Illustrated are individual tumors (Tumors A–D) with cells occupying varying levels of the differentiation hierarchy within a tumor. Distinct differentiation states are illustrated in separate colors. Based on the presumption that each differentiation state is associated most closely with a particular breast cancer intrinsic subtype, this would imply that multiple breast cancer subtypes can co-exist in a tumor. As such, combinatorial therapeutic approaches which account for each disease subtype present may be required for improved efficacy of treatment.
Figure 3
Figure 3. Integrated model of clonal evolution along with hierarchical heterogeneity
An illustration of intra-tumoral genetic heterogeneity as a result of clonal evolution (Each circle with varying color represents a different genetic subclone). In addition to the clonal diversity, each subclone may exhibit plasticity across a spectrum of differentiation states (Note: hierarchy and differentiation states are illustrated below each subclone, and subclones may exhibit plasticity across a different range of differentiation states).This integrated model illustrates the potential interplay between clonal evolution and hierarchical heterogeneity, where genetic sub-clones may have cells that span varying spectra of the differentiation hierarchy.

References

    1. Perou C, et al. Molecular portraits of human breast tumours. Nature. 2000;406:747–752. - PubMed
    1. Curtis C, et al. The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups. Nature. 2012;486(7403):346–52. - PMC - PubMed
    1. Network CGA. Comprehensive molecular portraits of human breast tumours. Nature. 2012;490(7418):61–70. - PMC - PubMed
    1. Marusyk A, et al. Intra-tumour heterogeneity: a looking glass for cancer? Nat Rev Cancer. 2012;12(5):323–34. - PubMed
    1. Teschendorff AE, et al. An immune response gene expression module identifies a good prognosis subtype in estrogen receptor negative breast cancer. Genome Biol. 2007;8(8):R157. - PMC - PubMed

Publication types

MeSH terms

Substances